ABSTRACT. The cleavage cycle, which is initiated by fertilization, consists of only S and M phases, and the gap phases (G1 and G2) appear after the midblastula transition (MBT) in the African clawed frog, Xenopus laevis. During early development in Xenopus, we examined the E2F activity, which controls transition from the G1 to S phase in the somatic cell cycle. Gel retardation and transactivation assays revealed that, although the E2F protein was constantly present throughout early development, the E2F transactivation activity was induced in a stagespecific manner, that is, low before MBT and rapidly increased after MBT. Introduction of the recombinant dominant negative E2F (dnE2F), but not the control, protein into the 2-cell stage embryos specifically suppressed E2F activation after MBT. Cells in dnE2F-injected embryos appeared normal before MBT, but ceased to proliferate and eventually died at the gastrula. These cells contained decreased cdk activity with enhanced inhibitory phosphorylation of Cdc2 at Tyr15. Thus, E2F activity is required for cell cycle progression and cell viability after MBT, but not essential for MBT transition and developmental progression during the cleavage stage.
Introduction
The E2F transcription factor is a crucial cell-cycle regulator responsible for the transition from G1 to S phase in the somatic cell cycle Dyson, 1998; Muller et al., 2001; Ohtani, 1999) . E2F regulates the expression of a variety of genes that are essential for cell cycle progression and DNA replication, such as cyclin A, Cdc2, Cdk2, DHFR (DeGregori et al., 1997) , cyclin E (Ohtani et al., 1995) , Cdc25A (Vigo et al., 1999) , and Cdc6 (Yan et al., 1998) . Whereas free E2F functions as a transcriptional activator together with histone acetyl transferase (HAT), E2F associated with a pocket protein such as a retinoblastoma protein (pRb) works as a transcriptional repressor with histone deacetylase (HDAC) activity (Harbour and Dean, 2000) . Sequential phosphorylations of the pocket protein by cyclinD/Cdk4 and cyclinE/Cdk2 at the transition from G1 to S phase result in the release of the free E2F from the pocket protein and transcriptional activation of the target genes (Sherr, 1996) . E2F thus has a crucial role in the G1/S regulatory system. The E2F transcription factor is composed of two proteins, an E2F and a DP protein. The E2F family contains 6 members, E2F1-6 in mammals, each of which associates with one of two members of the DP protein (Dyson, 1998) . Among the E2F family of proteins, E2F1, 2, and 3 play a central role in regulation of cell cycle progression from the G1 to S phase since ectopic expression of each gene induces S phase in quiescent fibroblasts (DeGregori et al., 1997; Lukas et al., 1996) . E2F1 and E2F3 also have the additional property of inducing apoptosis in cultured cells (Qin et al., 1994; Shan and Lee, 1994; Ziebold et al., 2001) .
Certain animals (Drosophila, zebra fish and African clawed frog) have a special cell cycle which consists of only two phases, DNA synthesis (S) and mitosis (M), during early development. During this stage, the progression of the cell cycle is mainly regulated by maternal transcripts and proteins, and the zygotic transcription is not required. In the African clawed frog, Xenopus laevis, this biphasic cell cycle is rapidly and synchronously repeated 12 times after fertilization (Newport and Kirschner, 1982a) . After the 12th division, progression of the cell cycle changes from the early-embryonic to the somatic-cell type (designated as the midblastula transition or MBT); the zygotic transcription is activated, cell synchrony among blastomeres is lost, and S and M phases are separated by two gap phases, G1 and G2, resulting in gradual elongation of the cell cycle (Graham and Morgan, 1966; Newport and Kirschner, 1982a) . However, the detailed mechanism by which MBT occurs is yet to be clarified.
To address the contribution of cell cycle regulators to early development, we focused on transcription factor E2F because it is recognized as the most downstream factor among the known G1/S regulators. E2F-specific transcriptional activity markedly increased after MBT, although E2F-specific binding activity was constantly present during early development. Introduction of a dominant-negative form of E2F (dnE2F) protein into embryos revealed that E2F activity is not required for the cell cycle progression during the cleavage stage and progression through MBT. After MBT, however, loss of E2F activity resulted in cell cycle arrest and eventual cell death.
Materials and Methods

Preparation of embryos and microinjection
Embryos were prepared by the standard method (Newport and Kirschner, 1982a ) and classified as described by Nieuwkoop and Faber (Nieuwkoop and Faber, 1956 ). Micro-injection of a protein or plasmid into embryos was performed in 4% Ficoll/0.1×MMR buffer (100 mM NaCl2, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2, and 5 mM HEPES pH 7.5). Injected embryos were cultured at 23°C.
Recombinant proteins
All recombinant proteins were prepared as glutathione S-transferase (GST) fusion proteins. The dnE2F protein contains only the DNA-binding domain of human E2F-1 and functions in Xenopus (Akamatsu et al., 1998; Dobrowolski et al., 1994) . A DNA fragment containing the GAL4 DNA-binding domain was amplified by PCR using a pair of specific primers (forward: 5'-GGATCCAT-GAAGCTACTGTCTTCTATCG-3', reverse: 5'-GAATTCGCGAT-ACAGTCAACTGTC-3') and the pAS1 vector as a template, and cloned into the pGEX-2T vector. Expression of the GST fusion proteins was induced in bacteria by the addition of 0.25 mM isopropyl-1-thio-b-D-galactopyranoside for 12 h at 18°C, and the proteins were purified by glutathione-Sepharose chromatography, with elution by 100 mM glutathione. Recombinant proteins were concentrated using Amicon Ultra spin columns (Millipore) in an injection buffer (88 mM NaCl, 7.5 mM MgCl2, 20 mM HEPES, 20 mM 2-mercaptoethanol, and 5% glycerol).
Reporter assay
Two hundred picograms of an E2F reporter plasmid, pEZ-WT-Luc (gift from Dr. K. Ohtani) and 20 pg of pCMVsport-bgal (Gibco BRL) were micro-injected together into both blastomeres of embryos at the 2 cell-stage with or without 20 ng of dnE2F protein.
Five embryos were collected at the indicated times, and homogenized in 100 ml of lysis buffer at room temperature. Twenty-five micro litters each were assayed for luciferase and b-galactosidase activities, respectively. The luciferase and b-galactosidase assays were carried out according to the manufacturer's instructions (Boehringer Mannheim).
Western blotting
Embryos were homogenized on ice in 5 ml per embryo of extraction buffer (50 mM Tris-HCl pH 8.0, 120 mM NaCl, 1 mM EDTA, and 0.5% NP40), and centrifuged for 5 min at 4°C. Proteins from two embryos per lane were separated by SDS-PAGE, transferred to a nitrocellulose membrane, and detected by the standard procedure (Akamatsu et al., 1998) . Polyclonal antibody was raised against bacterially produced His-tagged Xenopus Cyclin E polypeptides, affinity-purified, and used for immunoblotting. Anti-Cdc2 monoclonal antibody, anti-Cdc2 phospho-Tyr15 polyclonal antibody, anti-g-tublin monoclonal antibody, and anti-GST polyclonal antibody were obtained from Abcam, New England Biolabs, Sigma, and Santa Cruz, respectively.
Measurement of DNA content
Total DNA was extracted from embryos by a method described (Furuno et al., 1994) . Shortly after, 10 embryos were homogenized in 0.6 ml of genome extraction buffer (10 mM Tris-HCl pH 7.0, 10 mM EDTA, 1% SDS, and 100 mg/ml protease K) and incubated for 16 h at 37°C. Total DNA was isolated by phenol/chloroform extraction and ethanol precipitation. The resultant total DNA was used as a template for quantitative PCR with a pair of Xenopus cyclinD1-promoter-specific primers (forward: 5'-AAGAAGTG-GCTGGTCTCTGG-3', reverse: 5'-TGGCAGCCCTATCTATC-TCC-3'). The PCR products were separated by electrophoresis in a 1% agarose gel and stained with ethidium bromide. Signal intensity was quantified with a densitograph (ATTO).
In vitro kinase assay
The extracts from 5 embryos were incubated with p13Suc1-agarose beads (Upstate Biotechnology) for 1 h at 4°C. The beads were washed with low salt buffer (100 mM NaCl, 20 mM Tris-HCl pH 7.4, 5 mM EDTA, and 0.1% Triton X-100), high salt buffer (1 M NaCl, 20 mM Tris-HCl pH 7.4, 5 mM EDTA, and 0.1% Triton X-100), and kinase buffer (20 mM HEPES pH 7.5, 15 mM MgCl2, 5 mM EGTA, and 1 mM dithiothreitol). The beads were incubated in 25 ml of kinase buffer supplemented with 0.2 mg/ml bovine serum albumin, 0.2 mg/ml histone H1, and 50 mM [g- Fixation, sectioning and staining of embryos Embryos were fixed with MEMFA buffer (100 mM MOPS pH 7.4, 2 mM EGTA, 1 mM MgSO4, and 3.7% formaldehyde), and embedded into Tissue Tek OCT compound (SAKURA) at -80°C. Frozen embryos were sectioned at 8-mm in thickness by using a CRIOSTAD. Sections on micro glass slides were stained with Hoechst dye, and observed by fluorescence microscopy.
Results
DNA binding and transactivation activities of endogenous E2F during early development in Xenopus
During early development in Xenopus, transcription from zygotic genome is quiescent before MBT (Newport and Kirschner, 1982b) . To determine when transcription factor E2F is activated during early development, we first examined the DNA binding activity of endogenous E2F by performing the gel-retardation assay. Surprisingly, endogenous E2F was already present in unfertilized eggs and its level was constant throughout early development (Fig. 1A) . We detected only a single specific band, which did not shift during embryonic development, suggesting that regulation by pocket proteins does not play an essential role during these stages. Next, we micro-injected an E2F reporter plasmid into embryos at the 1-cell stage to investigate the E2F-mediated transactivation activity. Transcriptional activity of E2F was very low before MBT (5.5 hours after fertilization or stage 8) but rapidly increased after MBT (Fig. 1B) . Thus, although E2F transcription factor is present in a maternally inherited manner, it is quiescent before MBT through an uncharacterized mechanism, and is activated after MBT with a minimum change of the DNA binding activity.
Dominant-negative E2F suppress the activation of endogenous E2F after MBT
To address the function of the E2F activity in early development, we utilized a truncated form of E2F containing only the DNA binding domain known to act as a dominant-negative form of E2F (dnE2F: (Fan and Bertino, 1997; Zhang et al., 1999a) ). Recombinant dnE2F protein was expressed in bacteria and purified as a GST-tagged protein. The dnE2F protein was microinjected into embryos together with the E2F reporter plasmid, and the endogenous E2F activity was assayed at various times during early development. While endogenous E2F transcription activity in control embryos rapidly increased after MBT, the activation was barely detectable in dnE2F-injected embryos, and the repression continued for 17 hours after fertilization, when control embryos reached the neural stage (Fig. 2) . Western blotting showed that the injected dnE2F protein was present (data not shown). The gel retardation assay showed that dnE2F bound to a specific site on DNA, and its binding activity was stronger than that of endogenous Xenopus E2F (data not shown). Taken together, these results indicated that microinjection of the dnE2F protein into embryos effectively prevented the activation of E2F after MBT.
Abnormal morphology was seen specifically in embryos injected with dnE2F after MBT To address the effect of the repression of E2F activity, we microinjected the dnE2F protein into one hemisphere of each embryo at the 2-cell stage. Figure 3 shows that the Embryonic extracts prepared at the indicated hours after fertilization were used for the gel retardation assay; 1.5 hours after fertilization corresponds to stage 2, and the other times correspond to stages 6, 8, 9, 10, 11 and 12, respectively, in the order of development. (B) Transcriptional activation of E2F begins at MBT. Endogenous E2F activity was detected with microinjection of an E2F reporter construct (pEZ-WT-Luc), which has a luciferase gene as the reporter, into embryos.
dnE2F-injected embryos developed with normal appearance even in the blastula stage, compared with control embryos. Abnormal morphology eventually appeared at a later stage, at 9.5 hours after fertilization: the embryos treated with dnE2F had unnaturally large, white blastomeres (Fig. 3) , which is characteristic of disruption of intercellular contacts among blastomeres (Anderson et al., 1997; Shimuta et al., 2002) . This developmental abnormality was specific to dnE2F injection, because neither stimulation by needle injection (data not shown) nor introduction of the same quantity of control proteins (GST alone and GST fused with DNA binding domain of Gal4 transcription factor) induced abnormalities (Fig. 3) . In addition, the amount of the injected E2F protein was within a physiological level, comparable to that of proliferating NIH3T3 mouse fibroblasts. Thus, inhibition of E2F activation resulted in disruption of embryonic development not before but after MBT.
DnE2F inhibited cell cycle progression and proliferation during early development of Xenopus
To investigate the effect of dnE2F on the onset of MBT, we examined the timing of degradation of cyclin E protein (Howe and Newport, 1996) and phosphorylation of Cdc2 at Tyr 15 (Ferrell et al., 1991; Hartley et al., 1996) during early development (Fig. 4A) , both of which are well-known Fig. 2 . Microinjection of dnE2F fused to glutathione-S-transferase suppresses the endogenous E2F activation at and after MBT. E2F activity was detected as in Figure 1 (B). The embryos were collected at the indicated times after fertilization. Extract equivalent to two embryos was used for each assay. Fig. 3 . Abnormal phenotype initially occurs at the gastrula stage in embryos treated with dnE2F. Embryos were microinjected with 20 ng of the indicated GST-fusion protein in one hemisphere at the 2-cell stage (1.5 hours after fertilization). The blastomeres treated with dnE2F protein showed abnormal morphology at the gastrula stage, which is indicated by white arrowheads. markers for MBT. Western blot analiysis wth antibody specifically recognizing Xenopus cyclin E showed that cyclin E was maintained for 5.5 hours and rapidly disappeared by 7.5 hours after fertilization in control embryos, and was degraded in dnE2F-injected embryos as well with a slight delay (ca. 1-2 hours) (Fig. 4A, top panel) . Consistent with this, Cdc2 in control embryos began to be phosphorylated at Tyr 15 after 5.5 hours post fertilization, and Tyr15-phosphorylation in dnE2F-injected embryos occurred after 7.5 hours post fertilization (Fig 5A, third panel) . To examine whether the cell cycle progression is slowed down before MBT in these embryos, we quantitatively measured the genomic DNA content of the embryos by the quantitative genomic PCR method every 30 minutes from 5.5 hours after fertilization. Fig. 4B shows that replication of the genomic DNA in dnE2F-injected embryos was slower by half an hour to 1 hour than that in control embryos. Thus, dnE2F did not block MBT itself, but it may slightly slow down progression rate of the cleavage cycle.
Interestingly, after the onset of Tyr15-phosphorylation of Cdc2, it accumulated more in dnE2F-injected embryos at later time points. Therefore, we speculated that dnE2F-injection might disturb cell proliferation after MBT. In fact, the amount of total genomic DNA per embryo (representing the total cell number) reached a plateau in dnE2F-injected embryos by 9.5 hours after fertilization, while that of control embryos continuously increased (Fig. 5A) . Consistent with this observation, the total Cdk activity (Cdc2 plus Cdk2) was lower in a lysate prepared from dnE2F-injected embryos than that of control embryos (Fig. 5B) . Thus, downregulation of the E2F activity resulted in the blockade of cell cycle progression after the delayed MBT.
The recombinant dnE2F protein was injected into one hemisphere of the 2-cell stage embryos and the embryos were sectioned on an equatorial plane at 11.5 hours post fertilization. Staining of the section with Hoechst dye showed that the hemisphere injected with dnE2F contained a markedly reduced number of nuclei compared to the control hemisphere (Fig. 5C ), supporting the idea that E2F activation is essential for cell cycle progression after MBT.
Embryos injected with Xenopus dnE2F exhibited identical morphological characteristics as embryos injected with human dnE2F
Although E2F transcription factor is conserved among varieties of species from Drosophila to mammals and human dnE2F functions in Xenopus, we tested the effects of the DNA binding domain of the Xenopus E2F protein (Xenopus dnE2F). For this purpose, we isolated cDNA fragment encoding Xenopus E2F from the Xenopus embryonic cDNA library and subcloned the region equivalent to the human dnE2F into pGEX vector. Introduction of the recombinant Xenopus dnE2F protein into the fertilized eggs induced the identical phenotype that was observed in embryos injected with the human protein, supporting the conclusion that E2F activity is essential for cell cycle progression during early development after, but not before, MBT.
Discussion
G1 is the only phase during the cell cycle in which cells, in response to the extracellular signals, decide whether they continue cell cycle progression or undergo differentiation. Since G1 phase first appears after MBT coincidentally with the first sign of cellular differentiation during early development in Xenopus, molecular analysis of the G1 regulators during early development is the essential issue for the development and differentiation study as well as the cell cycle control (Lazaro et al., 2002; Tanaka et al., 2003; Zhang et al., 1999b) . To approach this problem, we focused on transcription factor E2F, which functions most downstream among known G1/S regulators. We found that the E2F activity, almost undetectable during the cleavage stage, rapidly and continuously increased after MBT. Suppression of the E2F activity by the dominant-negative protein inhibited the progression of the cell cycle after, but not before MBT, and eventually resulted in embryonic lethality.
In spite of the fact that the E2F-specific DNA binding activity was constant during early development, transcrip- tion from the ectopically introduced reporter construct was initiated immediately after MBT and continuously increased thereafter. Epigenetic modifications of genomic DNA such as methylation (Stancheva et al., 2002; Stancheva and Meehan, 2000) are reported to induce the transcriptional inactivation during the development of Xenopus. If this is the case, the activity of modification enzymes should be high in fertilized eggs and ectopic plasmids must be modified immediately after introduction. Another possibility is the E2F-specific regulation. In somatic mammalian cells, the E2F transcription factor is regulated by direct binding to the DP subunit and pocket proteins (Ohtani, 1999) , or by phosphorylation (Kitagawa et al., 1995; Krek et al., 1995; Morris et al., 2000; Peeper et al., 1995) . However, no difference of the E2F mobility during development seems to preclude this hypothesis. Thirdly, basic transcriptional machinery may be activated at or around MBT, which seems most feasible, but a recent report suggests that some transcription of mRNA from zygotic genome before MBT was active (Yang et al., 2002) , although the detailed analysis remains to be done.
We found that introduction of dnE2F into embryos at the 1-or 2-cell stage resulted in delayed timings of Tyr15-phosphorylation of Cdc2, degradation of cyclin E and genomic DNA replication. Since the GST-dnE2F protein used in this study inhibits transcription in a target-specific manner (transcription from the CMV promoter, which contains no E2F site, was not inhibited at all by dnE2F, data not shown), we are still unable to preclude the possibility that delay in the cleavage cell cycle progression is due to the transcriptional inhibition of the E2F target genes before MBT. In addition, the phenotypes of dnE2F-injected embryos closely resembled those in embryos introduced with the dominant-negative form of Xenopus Chk1 (Shimuta et al., 2002) , implying that E2F functions at MBT. Although the molecular mechanism of dnE2F-mediated cleavage cycle delay remains to be investigated, two hypotheses are possible: Extracts prepared from 5 oocytes, eggs and embryos at 7.5 and 11.5 hours after fertilization were incubated with p13Suc1-agarose beads. Each precipitate was used for a kinase assay with histone H1 as a substrate. Signal intensity was quantified and plotted on the graph. Cdk activities of oocytes and unfertilized eggs are shown as controls for lower and higher cdk activities, respectively. (C) The hemisphere injected with dnE2F contains a smaller number of nuclei and a larger volume of blastomeres than the control. Each hemisphere of an embryo at the 2-cell stage was micro-injected with or without dnE2F protein, and the embryos were sectioned on an equatorial plane at 11.5 hours after fertilization as schematized in upper panel. The section was stained with Hoechst dye (lower panel) and also observed by visible light microscopy (upper panel). one is that tight binding of dnE2F to the genomic DNA may result in nonspecific inhibition of DNA replication, and the other is that E2F-mediatd transcription actually plays a role before MBT. Further study is required to solve this issue.
The amount of genomic DNA in dnE2F-injected embryos ceased to increase after 7.5 hours post fertilization, indicating that introduction of dnE2F induced cell cycle arrest after MBT. Consistent with this, cdk activity was lower in dnE2F embryos at later time points. The morphological abnormality observed in this study was reported to be a characteristic of disconnection among cellular contacts in embryos, resulting in apoptosis (Anderson et al., 1997; Shimuta et al., 2002) . As a matter of fact, we actually detected the fragmented genomic DNA in dnE2F embryos at a later stage (data not shown). Although it is possible that aberrant cell cycle arrest induced apoptosis, E2F activation after MBT is required for viability of the cells.
A recent report by (Suzuki and Hemmati-Brivanlou, 2000) showed that Xenopus E2F has a novel function to induce the ventral and posterior region during development through regulation of region-specific gene expression. They microinjected dnE2F RNA into embryos at the 4-cell stage, and thus the actual expression of the protein occurred at much later stages than the time of injection. In our case, injection of dnE2F protein into the 1-or 2-cell-stage embryos resulted in cell cycle delay, followed by cell cycle arrest and embryonic death before the axis formation stage. Whatever the experimental design may be, E2F-mediated gene transcription controls various important cell responses and functions, such as axis formation and body plan determination as well as cell cycle progression and cell viability.
